[How I manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus  6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)].

[How I manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)].
Bull Cancer. 2017 Nov 20;:
Authors: Brissot E, Alsuliman T, Gruson B, Hermet E, Tirefort Y, Yakoub-Agha I, Alain S
Abstract
The French society of bone marrow transplantation and cell therapy (SFGM-TC) organizes annually workshops in the attempt to harmonize clinical practices between different francophone transplantation center. Here, we report our recommendations regarding the management of Epstein Barr virus reactivation and lymphoproliferative disorders, cytomegalovirus (CMV) and human herpes virus 6 (HHV6) after allogeneic stem cell transplantation.
PMID: 29169653 [PubMed - as supplied by publisher]

Source: Bulletin du Cancer - November 20, 2017 Category: Cancer & Oncology Authors: Brissot E, Alsuliman T, Gruson B, Hermet E, Tirefort Y, Yakoub-Agha I, Alain S Tags: Bull Cancer Source Type: research